Eve Technologies is a leading independent corporation dedicated to supporting biomedical and life science researchers while advancing clinical diagnostics in healthcare. With nearly two decades of experience, we have specialized in state-of-the-art assay technology, particularly multiplexing laser beads, ensuring unparalleled precision. As the first in Canada to embrace multiplex technology, Eve Technologies has been pivotal in numerous publications in esteemed journals, serving academia, government agencies, and entities in the private sector, including pharmaceutical and in-vitro diagnostic companies.
Our impact encompasses a wide spectrum of research areas, ranging from non-communicable diseases like hypertension and diabetes to conditions such as Alzheimer’s, irritable bowel, and kidney disease. We’ve also played a critical role in the study of infectious diseases like COVID-19. Offering an extensive array of multiplexing targets in our analyte menu, including categories like Cytokines, Chemokines, Cardiovascular Disease Markers, Cancer Markers, and Neuroscience Markers, we provide a comprehensive suite of options to cater to diverse research needs.
Our commitment to scientific excellence is evident in every facet of our Luminex assay services. Through the integration of cutting-edge technology and a client-centered approach, we are the preferred choice for researchers seeking precise and reliable analysis of biological samples. By fostering robust supplier relationships, we deliver cost-effective assay services. As a global pioneer, our services play a pivotal role in optimizing cost-effectiveness within research environments with limited financial resources. Partner with us to unlock new possibilities in your research endeavors.
Our aspiration is to be a distinguished company that stays faithful to the foundational goals of biotechnology: to facilitate and advance biomedical research.
At the core of Eve Technologies’ philosophy lies the conviction that we bear a responsibility to act in the best interest of our clients. Accordingly, we conduct our operations with the utmost respect and ethical integrity, ultimately benefiting both our clients and society through the services we offer. Our overarching mission is to bolster and elevate biomedical research by leveraging enabling technologies at affordable rates.
Materials and information provided and sent to Eve Technologies are kept private by the strictest security measures. Assay outcomes and experimental data are proprietary to our clients and are kept confidential. Eve Technologies does not disclose confidential information to third parties unless instructed to do so by the client.